Search Within

Marc Ladanyi

  1. "Journal of Thoracic Oncology"
Formats
  1. Journal Article (39)
  2. Meeting Abstract (38)
Groups
  1. Department of Pathology and Laboratory Medicine (77)
  2. GSK Faculty (77)
  3. Human Oncology and Pathogenesis Program (77)
  4. Tow Center for Developmental Oncology (TCDO) (77)
  5. Department of Medicine (66)
  6. Solid Tumor Oncology Division (66)

More Groups

People
  1. Mark Kris (36)
  2. Gregory Riely (31)
  3. Natasha Rekhtman (22)
  4. Maria Arcila (20)
  5. Romel Somwar (20)
  6. Alexander Drilon (18)

More People

Years
  1. 2025 (2)
  2. 2024 (6)
  3. 2023 (7)
  4. 2022 (3)
  5. 2021 (3)
  6. 2020 (3)

More Years

Publications
  1. Journal of Thoracic Oncology (77)
Publishers
  1. Elsevier Inc. (77)

Results (77)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Integrin-linked kinase drives drug-tolerant persister cell survival and EMT in response to EGFR inhibition in lung adenocarcinoma
    Meeting Abstract

    Shi, R.; Farnsworth, D. A.; Febres-Aldana, C. A.; Chow, J. L. M.; Sheena, R.; Atwal, T.; Marti, J. L. G.; Thomas, K. N.; Lee, C. M.; Awrey, S. J.; more...
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save
  • RRAS and RRAS2 hotspot mutations as novel actionable oncogenic drivers in lung adenocarcinoma
    Meeting Abstract

    Ladanyi, M.; Yang, S. R.; Zhang, T.; de Stanchina, E.; Somwar, R.
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save
  • RRAS and RRAS2 mutations are oncogenic drivers in lung cancer and are sensitive to the PAN-RAS inhibitor RMC-6236
    Meeting Abstract

    Pfeil, A. J.; Zhang, T.; Febres-Aldana, C. A.; Cheng, R.; Mattar, M. S.; Arbour, K.; Ladanyi, M.; Yang, S. R.; Somwar, R.
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Integrin-linked kinase facilitates drug tolerant persister cell survival and EMT in response to EGFR targeted therapy
    Meeting Abstract

    Shi, R.; Farnsworth, D.; Atwal, T.; Chow, J.; Sheena, R.; Lee, C. M.; Inoue, Y.; Awrey, S.; McDonald, P.; Somwar, R.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Comprehensive pan-cancer analysis of oncogenic MET rearrangements with a focus on targetability in NSCLC
    Meeting Abstract

    Vojnic, M.; Febres-Aldana, C. A.; Odintsov, I.; Zhang, T.; Beach, C. Z.; Lu, D.; Mattar, M. S.; Gazzo, A.; Gili, L.; Harshan, M.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Prevalence and therapeutic targeting of high-level ERBB2 amplification in NSCLC
    Journal Article

    Odintsov, I.; Makarem, M.; Nishino, M.; Bachert, S. E.; Zhang, T.; LoPiccolo, J.; Paweletz, C. P.; Gokhale, P. C.; Ivanova, E.; Saldanha, A.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Microsatellite instability and mismatch repair deficiency define a distinct subset of lung cancers characterized by smoking exposure, high tumor mutational burden, and recurrent somatic MLH1 inactivation
    Journal Article

    Yang, S. R.; Gedvilaite, E.; Ptashkin, R.; Chang, J.; Ziegler, J.; Mata, D. A.; Villafania, L. B.; Nafa, K.; Hechtman, J. F.; Benayed, R.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • HER4 and EGFR activate cell signaling in NRG1 fusion-driven cancers: Implications for HER2-HER3-specific versus pan-HER targeting strategies
    Journal Article

    Udagawa, H.; Nilsson, M. B.; Robichaux, J. P.; He, J.; Poteete, A.; Jiang, H.; Heeke, S.; Elamin, Y. Y.; Shibata, Y.; Matsumoto, S.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of patients with EGFR-mutant lung cancer with acquired BRAF alterations
    Meeting Abstract

    Sui, J.; Yang, S. R.; Bowman, A. S.; Vankayala, P.; Falcon, C.; Somwar, R.; Drilon, A. E.; Riely, G. J.; Kris, M. G.; Ladanyi, M.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Microsatellite instability defines a subset of lung cancers with smoking exposure, high tumor mutational burden and MLH1 inactivation
    Meeting Abstract

    Yang, S. R.; Gedvilaite, E.; Ptashkin, R.; Chang, J.; Ziegler, J.; Mata, D.; Villafania, L. B.; Nafa, K.; Hechtman, J. F.; Benhamida, J.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save